# Lansoprazole

NDC: 65862-895
Generic name: Lansoprazole
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Routes: ORAL
Marketing started: 20230328

FDA application: ANDA207167

## Active ingredients

- LANSOPRAZOLE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-895"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-895
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f2883d8-12db-40b7-9104-22a6690a22a7